Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue

• Egile Nagusiak: Shintaro Sugita (Egilea), Tomoko Takenami (Egilea), Tomomi Kido (Egilea), Tomoyuki Aoyama (Egilea), Michiko Hosaka (Egilea), Keiko Segawa (Egilea), Taro Sugawara (Egilea), Hiromi Fujita (Egilea), Junya Shimizu (Egilea), Yasutaka Murahashi (Egilea), Makoto Emori (Egilea), Tadashi Hasegawa (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Tenosynovial giant cell tumor (TSGCT) is a benign fibrohistiocytic tumor that affects the synovium of joints, bursa, and tendon sheaths and is categorized into localized TSGCT (LTSGCT) and diffuse TSGCT (DTSGCT). LTSGCT and DTSGCT are characterized by recurrent fusions involving...